Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy
出版年份 2017 全文链接
标题
Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy
作者
关键词
Ovarian clear cell carcinoma, Immunohistochemistry, Chemoresistance, Aurora kinase A, Programmed death ligand-1
出版物
Journal of Ovarian Research
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-02-11
DOI
10.1186/s13048-017-0304-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer
- (2016) Phillip P. Santoiemma et al. GYNECOLOGIC ONCOLOGY
- PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
- (2016) John R. Webb et al. GYNECOLOGIC ONCOLOGY
- Molecular Profiling of Clear Cell Ovarian Cancers
- (2016) Michael L. Friedlander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
- (2016) Seiji Mabuchi et al. Journal of Gynecologic Oncology
- High levels of EGFR expression in tumor stroma are associated with aggressive clinical features in epithelial ovarian cancer
- (2016) Ke Wang et al. OncoTargets and Therapy
- PD-L1 expression in human cancers and its association with clinical outcomes
- (2016) Jinming Yu et al. OncoTargets and Therapy
- miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint
- (2016) Shaohua Xu et al. Nature Communications
- Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients
- (2016) Chiara Mignogna et al. Journal of Ovarian Research
- The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
- (2015) Seiji Mabuchi et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy
- (2015) Y. Yamashita JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Targeting Programmed Cell Death 1 in Ovarian Cancer
- (2015) Krisztian Homicsko et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Aurora kinase A in gastrointestinal cancers: time to target
- (2015) Ahmed Katsha et al. Molecular Cancer
- Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary
- (2015) Nozomu Yanaihara et al. MOLECULAR CARCINOGENESIS
- Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy
- (2015) Maria Isabella Sereni et al. PROTEOMICS
- Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling
- (2015) Ronald L. Chandler et al. Nature Communications
- A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
- (2015) Moria H Belanger et al. Journal of Ovarian Research
- Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma
- (2015) Aikou Okamoto et al. PLoS One
- Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary
- (2014) Aikou Okamoto et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary
- (2014) Tomoyuki Sasano et al. MOLECULAR CANCER RESEARCH
- Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancer
- (2013) Maurie Markman GYNECOLOGIC ONCOLOGY
- A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer
- (2012) S. B. Kaye et al. ANNALS OF ONCOLOGY
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
- (2011) Michael S. Anglesio et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study
- (2011) Agustin A. Garcia et al. GYNECOLOGIC ONCOLOGY
- Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations
- (2011) Sohei Yamamoto et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma
- (2010) K. T. Kuo et al. CLINICAL CANCER RESEARCH
- Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
- (2010) Stephanie V. Blank et al. GYNECOLOGIC ONCOLOGY
- Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma
- (2010) Heini Lassus et al. GYNECOLOGIC ONCOLOGY
- Gene Expression Profile ofBRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
- (2010) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
- (2009) P de Graeff et al. BRITISH JOURNAL OF CANCER
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- The aurora kinase A regulates GSK-3β in gastric cancer cells
- (2008) A A Dar et al. ONCOGENE
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started